ID   GPDA_HUMAN              Reviewed;         349 AA.
AC   P21695; F8W1L5; Q8N1B0;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 4.
DT   10-MAY-2017, entry version 168.
DE   RecName: Full=Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic;
DE            Short=GPD-C;
DE            Short=GPDH-C;
DE            EC=1.1.1.8;
GN   Name=GPD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT PRO-113.
RC   TISSUE=Liver;
RX   PubMed=7772607; DOI=10.1016/0167-4781(95)00069-S;
RA   Menaya J., Gonzalez-Manchon C., Parrilla R., Ayuso M.S.;
RT   "Molecular cloning, sequencing and expression of a cDNA encoding a
RT   human liver NAD-dependent alpha-glycerol-3-phosphate dehydrogenase.";
RL   Biochim. Biophys. Acta 1262:91-94(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Macrophage;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-14.
RC   TISSUE=Fetal liver;
RX   PubMed=2398890; DOI=10.1128/MCB.10.10.5244;
RA   Gwynn B., Lyford K.L., Birkenmeier E.H.;
RT   "Sequence conservation and structural organization of the glycerol-3-
RT   phosphate dehydrogenase promoter in mice and humans.";
RL   Mol. Cell. Biol. 10:5244-5256(1990).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [7]
RP   INVOLVEMENT IN HTGTI, AND VARIANTS VAL-54; LYS-124; ALA-197 AND
RP   ILE-223.
RX   PubMed=22226083; DOI=10.1016/j.ajhg.2011.11.028;
RA   Basel-Vanagaite L., Zevit N., Zahav A.H., Guo L., Parathath S.,
RA   Pasmanik-Chor M., McIntyre A.D., Wang J., Albin-Kaplanski A.,
RA   Hartman C., Marom D., Zeharia A., Badir A., Shoerman O., Simon A.J.,
RA   Rechavi G., Shohat M., Hegele R.A., Fisher E.A., Shamir R.;
RT   "Transient infantile hypertriglyceridemia, fatty liver, and hepatic
RT   fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate
RT   dehydrogenase 1.";
RL   Am. J. Hum. Genet. 90:49-60(2012).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-154, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH NAD, SUBUNIT,
RP   AND ENZYME REGULATION.
RX   PubMed=16460752; DOI=10.1016/j.jmb.2005.12.074;
RA   Ou X., Ji C., Han X., Zhao X., Li X., Mao Y., Wong L.-L., Bartlam M.,
RA   Rao Z.;
RT   "Crystal structures of human glycerol 3-phosphate dehydrogenase 1
RT   (GPD1).";
RL   J. Mol. Biol. 357:858-869(2006).
RN   [10]
RP   VARIANT HTGTI PRO-229.
RX   PubMed=24549054; DOI=10.1038/ejhg.2014.8;
RA   Joshi M., Eagan J., Desai N.K., Newton S.A., Towne M.C.,
RA   Marinakis N.S., Esteves K.M., De Ferranti S., Bennett M.J.,
RA   McIntyre A., Beggs A.H., Berry G.T., Agrawal P.B.;
RT   "A compound heterozygous mutation in GPD1 causes hepatomegaly,
RT   steatohepatitis, and hypertriglyceridemia.";
RL   Eur. J. Hum. Genet. 22:1229-1232(2014).
CC   -!- CATALYTIC ACTIVITY: sn-glycerol 3-phosphate + NAD(+) = glycerone
CC       phosphate + NADH.
CC   -!- ENZYME REGULATION: Inhibited by zinc ions and sulfate.
CC       {ECO:0000269|PubMed:16460752}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:16460752}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P21695-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P21695-2; Sequence=VSP_045999;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Hypertriglyceridemia, transient infantile (HTGTI)
CC       [MIM:614480]: An autosomal recessive disorder characterized by
CC       onset of moderate to severe transient hypertriglyceridemia in
CC       infancy that normalizes with age. The hypertriglyceridemia is
CC       associated with hepatomegaly, moderately elevated transaminases,
CC       persistent fatty liver, and the development of hepatic fibrosis.
CC       {ECO:0000269|PubMed:22226083, ECO:0000269|PubMed:24549054}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the NAD-dependent glycerol-3-phosphate
CC       dehydrogenase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L34041; AAA92863.1; -; mRNA.
DR   EMBL; AK130162; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC025154; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC032234; AAH32234.1; -; mRNA.
DR   EMBL; M36917; AAA35925.1; -; Genomic_DNA.
DR   CCDS; CCDS58229.1; -. [P21695-2]
DR   CCDS; CCDS8799.1; -. [P21695-1]
DR   PIR; S55920; S55920.
DR   RefSeq; NP_001244128.1; NM_001257199.1. [P21695-2]
DR   RefSeq; NP_005267.2; NM_005276.3. [P21695-1]
DR   UniGene; Hs.524418; -.
DR   PDB; 1WPQ; X-ray; 2.50 A; A/B=1-349.
DR   PDB; 1X0V; X-ray; 2.30 A; A/B=1-349.
DR   PDB; 1X0X; X-ray; 2.75 A; A=1-349.
DR   PDBsum; 1WPQ; -.
DR   PDBsum; 1X0V; -.
DR   PDBsum; 1X0X; -.
DR   ProteinModelPortal; P21695; -.
DR   SMR; P21695; -.
DR   BioGrid; 109080; 8.
DR   IntAct; P21695; 3.
DR   MINT; MINT-1429375; -.
DR   STRING; 9606.ENSP00000301149; -.
DR   DrugBank; DB00157; NADH.
DR   SwissLipids; SLP:000000645; -.
DR   iPTMnet; P21695; -.
DR   PhosphoSitePlus; P21695; -.
DR   BioMuta; GPD1; -.
DR   DMDM; 134047785; -.
DR   MaxQB; P21695; -.
DR   PaxDb; P21695; -.
DR   PeptideAtlas; P21695; -.
DR   PRIDE; P21695; -.
DR   DNASU; 2819; -.
DR   Ensembl; ENST00000301149; ENSP00000301149; ENSG00000167588. [P21695-1]
DR   Ensembl; ENST00000548814; ENSP00000446768; ENSG00000167588. [P21695-2]
DR   GeneID; 2819; -.
DR   KEGG; hsa:2819; -.
DR   UCSC; uc001rvz.5; human. [P21695-1]
DR   CTD; 2819; -.
DR   DisGeNET; 2819; -.
DR   GeneCards; GPD1; -.
DR   HGNC; HGNC:4455; GPD1.
DR   HPA; HPA044620; -.
DR   MalaCards; GPD1; -.
DR   MIM; 138420; gene.
DR   MIM; 614480; phenotype.
DR   neXtProt; NX_P21695; -.
DR   OpenTargets; ENSG00000167588; -.
DR   Orphanet; 300293; Transient infantile hypertriglyceridemia and hepatosteatosis.
DR   PharmGKB; PA28836; -.
DR   eggNOG; KOG2711; Eukaryota.
DR   eggNOG; COG0240; LUCA.
DR   GeneTree; ENSGT00390000003114; -.
DR   HOGENOM; HOG000246855; -.
DR   HOVERGEN; HBG003669; -.
DR   InParanoid; P21695; -.
DR   KO; K00006; -.
DR   OMA; NFCEATI; -.
DR   OrthoDB; EOG091G0DO6; -.
DR   PhylomeDB; P21695; -.
DR   TreeFam; TF300836; -.
DR   BioCyc; MetaCyc:HS09586-MONOMER; -.
DR   BRENDA; 1.1.1.8; 2681.
DR   Reactome; R-HSA-1483166; Synthesis of PA.
DR   Reactome; R-HSA-75109; Triglyceride Biosynthesis.
DR   SABIO-RK; P21695; -.
DR   ChiTaRS; GPD1; human.
DR   EvolutionaryTrace; P21695; -.
DR   GenomeRNAi; 2819; -.
DR   PRO; PR:P21695; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000167588; -.
DR   CleanEx; HS_GPD1; -.
DR   ExpressionAtlas; P21695; baseline and differential.
DR   Genevisible; P21695; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0009331; C:glycerol-3-phosphate dehydrogenase complex; IEA:InterPro.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0004367; F:glycerol-3-phosphate dehydrogenase [NAD+] activity; TAS:Reactome.
DR   GO; GO:0004368; F:glycerol-3-phosphate dehydrogenase activity; IEA:Ensembl.
DR   GO; GO:0051287; F:NAD binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:InterPro.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0071356; P:cellular response to tumor necrosis factor; IEA:Ensembl.
DR   GO; GO:0006094; P:gluconeogenesis; IEA:Ensembl.
DR   GO; GO:0046168; P:glycerol-3-phosphate catabolic process; IEA:InterPro.
DR   GO; GO:0006127; P:glycerophosphate shuttle; IEA:Ensembl.
DR   GO; GO:0006654; P:phosphatidic acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0045821; P:positive regulation of glycolytic process; IEA:Ensembl.
DR   GO; GO:0019432; P:triglyceride biosynthetic process; TAS:Reactome.
DR   Gene3D; 1.10.1040.10; -; 1.
DR   InterPro; IPR008927; 6-PGluconate_DH_C-like.
DR   InterPro; IPR013328; 6PGD_dom_2.
DR   InterPro; IPR006168; G3P_DH_NAD-dep.
DR   InterPro; IPR006109; G3P_DH_NAD-dep_C.
DR   InterPro; IPR017751; G3P_DH_NAD-dep_euk.
DR   InterPro; IPR011128; G3P_DH_NAD-dep_N.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF07479; NAD_Gly3P_dh_C; 1.
DR   Pfam; PF01210; NAD_Gly3P_dh_N; 1.
DR   PIRSF; PIRSF000114; Glycerol-3-P_dh; 1.
DR   PRINTS; PR00077; GPDHDRGNASE.
DR   SUPFAM; SSF48179; SSF48179; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR03376; glycerol3P_DH; 1.
DR   PROSITE; PS00957; NAD_G3PDH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Disease mutation; NAD; Oxidoreductase; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN         1    349       Glycerol-3-phosphate dehydrogenase
FT                                [NAD(+)], cytoplasmic.
FT                                /FTId=PRO_0000138079.
FT   NP_BIND      10     15       NAD. {ECO:0000269|PubMed:16460752}.
FT   REGION      269    270       Substrate binding.
FT   ACT_SITE    204    204       Proton acceptor. {ECO:0000305}.
FT   BINDING      41     41       NAD. {ECO:0000269|PubMed:16460752}.
FT   BINDING      97     97       NAD. {ECO:0000269|PubMed:16460752}.
FT   BINDING     120    120       Substrate.
FT   BINDING     153    153       NAD; via amide nitrogen.
FT                                {ECO:0000269|PubMed:16460752}.
FT   BINDING     269    269       NAD. {ECO:0000269|PubMed:16460752}.
FT   BINDING     296    296       NAD; via amide nitrogen.
FT                                {ECO:0000269|PubMed:16460752}.
FT   BINDING     298    298       NAD. {ECO:0000269|PubMed:16460752}.
FT   MOD_RES     154    154       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     289    289       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P13707}.
FT   MOD_RES     326    326       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:O35077}.
FT   VAR_SEQ      74     96       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045999.
FT   VARIANT      54     54       I -> V (in dbSNP:rs2232202).
FT                                {ECO:0000269|PubMed:22226083}.
FT                                /FTId=VAR_029492.
FT   VARIANT     113    113       A -> P (in dbSNP:rs1128867).
FT                                {ECO:0000269|PubMed:7772607}.
FT                                /FTId=VAR_029493.
FT   VARIANT     124    124       E -> K (in dbSNP:rs34783513).
FT                                {ECO:0000269|PubMed:22226083}.
FT                                /FTId=VAR_067425.
FT   VARIANT     197    197       V -> A (in dbSNP:rs2232207).
FT                                {ECO:0000269|PubMed:22226083}.
FT                                /FTId=VAR_049220.
FT   VARIANT     223    223       T -> I (in dbSNP:rs200251017).
FT                                {ECO:0000269|PubMed:22226083}.
FT                                /FTId=VAR_067426.
FT   VARIANT     229    229       R -> P (in HTGTI; dbSNP:rs199673455).
FT                                {ECO:0000269|PubMed:24549054}.
FT                                /FTId=VAR_071967.
FT   STRAND        4      9       {ECO:0000244|PDB:1X0V}.
FT   HELIX        13     28       {ECO:0000244|PDB:1X0V}.
FT   STRAND       32     39       {ECO:0000244|PDB:1X0V}.
FT   STRAND       44     49       {ECO:0000244|PDB:1X0V}.
FT   HELIX        50     57       {ECO:0000244|PDB:1X0V}.
FT   TURN         61     63       {ECO:0000244|PDB:1X0V}.
FT   STRAND       73     78       {ECO:0000244|PDB:1X0V}.
FT   HELIX        79     83       {ECO:0000244|PDB:1X0V}.
FT   STRAND       87     91       {ECO:0000244|PDB:1X0V}.
FT   HELIX        95     97       {ECO:0000244|PDB:1X0V}.
FT   HELIX        98    105       {ECO:0000244|PDB:1X0V}.
FT   STRAND      114    117       {ECO:0000244|PDB:1X0V}.
FT   STRAND      124    128       {ECO:0000244|PDB:1X0V}.
FT   HELIX       132    140       {ECO:0000244|PDB:1X0V}.
FT   STRAND      144    148       {ECO:0000244|PDB:1X0V}.
FT   HELIX       153    157       {ECO:0000244|PDB:1X0V}.
FT   STRAND      162    167       {ECO:0000244|PDB:1X0V}.
FT   HELIX       171    181       {ECO:0000244|PDB:1X0V}.
FT   STRAND      186    192       {ECO:0000244|PDB:1X0V}.
FT   HELIX       194    216       {ECO:0000244|PDB:1X0V}.
FT   HELIX       221    242       {ECO:0000244|PDB:1X0V}.
FT   STRAND      243    245       {ECO:0000244|PDB:1X0V}.
FT   HELIX       249    253       {ECO:0000244|PDB:1X0V}.
FT   TURN        255    257       {ECO:0000244|PDB:1X0V}.
FT   HELIX       258    267       {ECO:0000244|PDB:1X0V}.
FT   HELIX       269    280       {ECO:0000244|PDB:1X0V}.
FT   HELIX       284    291       {ECO:0000244|PDB:1X0V}.
FT   HELIX       298    313       {ECO:0000244|PDB:1X0V}.
FT   HELIX       316    318       {ECO:0000244|PDB:1X0V}.
FT   HELIX       320    330       {ECO:0000244|PDB:1X0V}.
FT   HELIX       335    338       {ECO:0000244|PDB:1X0V}.
FT   HELIX       339    343       {ECO:0000244|PDB:1X0V}.
SQ   SEQUENCE   349 AA;  37568 MW;  CE7B7681103076EF CRC64;
     MASKKVCIVG SGNWGSAIAK IVGGNAAQLA QFDPRVTMWV FEEDIGGKKL TEIINTQHEN
     VKYLPGHKLP PNVVAVPDVV QAAEDADILI FVVPHQFIGK ICDQLKGHLK ANATGISLIK
     GVDEGPNGLK LISEVIGERL GIPMSVLMGA NIASEVADEK FCETTIGCKD PAQGQLLKEL
     MQTPNFRITV VQEVDTVEIC GALKNVVAVG AGFCDGLGFG DNTKAAVIRL GLMEMIAFAK
     LFCSGPVSSA TFLESCGVAD LITTCYGGRN RKVAEAFART GKSIEQLEKE LLNGQKLQGP
     ETARELYSIL QHKGLVDKFP LFMAVYKVCY EGQPVGEFIH CLQNHPEHM
//
